Target intelligence / Profile preview

Influenza A virus hemagglutinin H7 (None)

Target
None
Molecular classification
Viral protein, Glycoprotein, Type I membrane protein
01

Overview

Influenza A virus hemagglutinin (HA) is the most abundant glycoprotein on the surface of influenza virions and plays a central role in viral entry into host cells. The H7 subtype refers to one of several antigenically distinct forms of HA found in influenza A viruses, with particular relevance for avian and zoonotic infections. HA binds sialic acid-containing receptors on vertebrate cell surfaces via its HA1 domain, enabling viral attachment and subsequent endocytosis. Acidification within endosomes triggers conformational changes in HA, and the fusion peptide (part of HA2) inserts into the endosomal membrane, facilitating fusion between viral and cellular membranes—releasing viral RNA into the cytoplasm for replication. As a major antigenic determinant, HA is the target of neutralizing antibodies; antigenic drift and shift can compromise immunity. H7 strains are primarily associated with avian hosts but have caused human infections.

Other names
H7 HemagglutininHA H7H7 HA
02

Mechanism of action

Attachment to host cell receptors and membrane fusion

03

Biological functions

Receptor bindingMembrane fusionViral entry
04

Disease associations

InfectionInfluenzaAvian influenzaZoonotic disease
05

Safety considerations

Antigenic driftAntigenic shiftPotential for pandemic spreadZoonotic transmission

Beyond the preview

Go deeper on Influenza A virus hemagglutinin H7 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin H7 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call